120 related articles for article (PubMed ID: 19404973)
1. Should patients with rheumatoid arthritis receive statin therapy?
Ridker PM; Solomon DH
Arthritis Rheum; 2009 May; 60(5):1205-9. PubMed ID: 19404973
[No Abstract] [Full Text] [Related]
2. Statin treatment of rheumatoid arthritis: comment on the editorial by Ridker and Solomon.
Peters MJ; Nurmohamed MT; Kitas GD; Sattar N
Arthritis Rheum; 2010 Jan; 62(1):302-3. PubMed ID: 20039426
[No Abstract] [Full Text] [Related]
3. Cardiovascular health. Statin therapy reduces disease in healthy volunteers--but how, exactly?
Couzin J
Science; 2008 Nov; 322(5904):1039. PubMed ID: 19008423
[No Abstract] [Full Text] [Related]
4. Observing JUPITER. Trial results are likely to expand statin use and testing for CRP.
Harv Heart Lett; 2009 Jan; 19(5):2. PubMed ID: 19575511
[No Abstract] [Full Text] [Related]
5. [The JUPITER study].
Gaspardone A; Maseri A
G Ital Cardiol (Rome); 2009 May; 10(5):267-70. PubMed ID: 19537439
[No Abstract] [Full Text] [Related]
6. Rosuvastatin in patients with elevated C-reactive protein.
Jenny-Avital ER
N Engl J Med; 2009 Mar; 360(10):1039; author reply 1041-2. PubMed ID: 19271275
[No Abstract] [Full Text] [Related]
7. [Statin cuts cardiovascular risk in half].
Einecke D
MMW Fortschr Med; 2008 Dec; 150(49-50):12-3. PubMed ID: 19133364
[No Abstract] [Full Text] [Related]
8. Ask the doctor. My rheumatoid arthritis gives me trouble in spite of my medications. I have read that statins, in addition to lowering cholesterol, also calm inflammation. Would taking a statin help my arthritis?
Shmerling R
Harv Heart Lett; 2006 Jan; 16(5):8. PubMed ID: 16450445
[No Abstract] [Full Text] [Related]
9. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
Mora S; Ridker PM
Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular disease: C-reactive protein and the inflammatory disease paradigm: HMG-CoA reductase inhibitors, alpha-tocopherol, red yeast rice, and olive oil polyphenols. A review of the literature.
Patrick L; Uzick M
Altern Med Rev; 2001 Jun; 6(3):248-71. PubMed ID: 11410071
[TBL] [Abstract][Full Text] [Related]
11. Relationship between uncontrolled risk factors and C-reactive protein levels in patients receiving standard or intensive statin therapy for acute coronary syndromes in the PROVE IT-TIMI 22 trial.
Ray KK; Cannon CP; Cairns R; Morrow DA; Rifai N; Kirtane AJ; McCabe CH; Skene AM; Gibson CM; Ridker PM; Braunwald E;
J Am Coll Cardiol; 2005 Oct; 46(8):1417-24. PubMed ID: 16226164
[TBL] [Abstract][Full Text] [Related]
12. Can statins help healthy people?
Johns Hopkins Med Lett Health After 50; 2009 Mar; 21(1):1. PubMed ID: 19370796
[No Abstract] [Full Text] [Related]
13. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease.
Guijarro C
Circulation; 2001 Nov; 104(22):E127. PubMed ID: 11723039
[No Abstract] [Full Text] [Related]
14. Predicting benefit from statins by C-reactive protein, LDL-cholesterol or absolute cardiovascular risk.
Stewart RA
Future Cardiol; 2009 May; 5(3):231-6. PubMed ID: 19656039
[TBL] [Abstract][Full Text] [Related]
15. Public health. U.S. panel favors wider use of preventive drug treatment.
Couzin-Frankel J
Science; 2010 Jan; 327(5962):130-1. PubMed ID: 20056859
[No Abstract] [Full Text] [Related]
16. Should we measure C-reactive protein levels to ascertain the adequacy of statin therapy in patients who are at very high risk for a coronary heart disease event?
Goyal A; Blazing M
Am Heart J; 2005 Oct; 150(4):650-1. PubMed ID: 16209959
[No Abstract] [Full Text] [Related]
17. The biology, utilization, and attenuation of C-reactive protein in cardiovascular disease: part II.
Armani A; Becker RC
Am Heart J; 2005 Jun; 149(6):977-83. PubMed ID: 15976778
[No Abstract] [Full Text] [Related]
18. Rosuvastatin in patients with elevated C-reactive protein.
Chan PS; Nallamothu BK; Hayward RA
N Engl J Med; 2009 Mar; 360(10):1039; author reply 1041-2. PubMed ID: 19271273
[No Abstract] [Full Text] [Related]
19. Effects of Angiotensin-converting enzyme inhibition and statin treatment on inflammatory markers and endothelial functions in patients with longterm rheumatoid arthritis.
Tikiz C; Utuk O; Pirildar T; Bayturan O; Bayindir P; Taneli F; Tikiz H; Tuzun C
J Rheumatol; 2005 Nov; 32(11):2095-101. PubMed ID: 16265685
[TBL] [Abstract][Full Text] [Related]
20. Rosuvastatin in patients with elevated C-reactive protein.
Koller MT; Bucher HC; Steyerberg EW
N Engl J Med; 2009 Mar; 360(10):1041; author reply 1041-2. PubMed ID: 19271276
[No Abstract] [Full Text] [Related]
[Next] [New Search]
